Compagnie Lombard Odier SCmA’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.3K | Sell |
92
-68
| -43% | -$18.8K | ﹤0.01% | 408 |
|
|
2026
Q1 | $47.3K | Sell |
160
-987
| -86% | -$293K | ﹤0.01% | 333 |
|
|
2025
Q4 | $313K | Hold |
1,147
| – | – | ﹤0.01% | 228 |
|
|
2025
Q3 | $310K | Buy |
1,147
+1,055
| +1,147% | +$287K | ﹤0.01% | 228 |
|
|
2025
Q2 | $25.4K | Hold |
92
| – | – | ﹤0.01% | 358 |
|
|
2025
Q1 | $24.4K | Hold |
92
| – | – | ﹤0.01% | 396 |
|
|
2024
Q4 | $21.4K | Sell |
92
-93
| -50% | -$21.4K | ﹤0.01% | 387 |
|
|
2024
Q3 | $40.8K | Hold |
185
| – | – | ﹤0.01% | 354 |
|
|
2024
Q2 | $36.4K | Hold |
185
| – | – | ﹤0.01% | 354 |
|
|
2024
Q1 | $39.8K | Sell |
185
-467
| -72% | -$98.1K | ﹤0.01% | 371 |
|
|
2023
Q4 | $137K | Buy |
652
+469
| +256% | +$100K | ﹤0.01% | 327 |
|
|
2023
Q3 | $36.6K | Buy |
+183
| New | +$36.4K | ﹤0.01% | 451 |
|
|
2022
Q2 | – | Sell |
-260
| Closed | -$62K | – | 610 |
|
|
2022
Q1 | $62K | Hold |
260
| – | – | ﹤0.01% | 423 |
|
|
2021
Q4 | $59K | Hold |
260
| – | – | ﹤0.01% | 487 |
|
|
2021
Q3 | $50K | Hold |
260
| – | – | ﹤0.01% | 500 |
|
|
2021
Q2 | $55K | Hold |
260
| – | – | ﹤0.01% | 477 |
|
|
2021
Q1 | $53K | Hold |
260
| – | – | ﹤0.01% | 503 |
|
|
2020
Q4 | $47K | Sell |
260
-93
| -26% | -$15.8K | ﹤0.01% | 446 |
|
|
2020
Q3 | $60K | Buy |
353
+93
| +36% | +$15.7K | ﹤0.01% | 376 |
|
|
2020
Q2 | $42K | Sell |
260
-76
| -23% | -$13.6K | ﹤0.01% | 394 |
|
|
2020
Q1 | $58K | Buy |
336
+76
| +29% | +$15.1K | ﹤0.01% | 344 |
|
|
2019
Q4 | $52K | Hold |
260
| – | – | ﹤0.01% | 353 |
|
|
2019
Q3 | $55K | Hold |
260
| – | – | ﹤0.01% | 355 |
|
|
2019
Q2 | $50K | Hold |
260
| – | – | ﹤0.01% | 359 |
|
|
2019
Q1 | $43K | Hold |
260
| – | – | ﹤0.01% | 409 |
|
|
2018
Q4 | $49K | Sell |
260
-8
| -3% | -$1.48K | ﹤0.01% | 392 |
|
|
2018
Q3 | $45K | Sell |
268
-172
| -39% | -$29K | ﹤0.01% | 435 |
|
|
2018
Q2 | $72K | Buy |
+440
| New | +$71.9K | ﹤0.01% | 394 |
|
|
2017
Q3 | – | Sell |
-500
| Closed | -$63K | – | 690 |
|
|
2017
Q2 | $63K | Buy |
+500
| New | +$59.8K | ﹤0.01% | 492 |
|
|
2014
Q4 | – | Sell |
-1,400
| Closed | -$112K | – | 780 |
|
|
2014
Q3 | $112K | Hold |
1,400
| – | – | ﹤0.01% | 625 |
|
|
2014
Q2 | $99K | Hold |
1,400
| – | – | ﹤0.01% | 674 |
|
|
2014
Q1 | $104K | Hold |
1,400
| – | – | ﹤0.01% | 646 |
|
|
2013
Q4 | $110K | Buy |
+1,400
| New | +$110K | ﹤0.01% | 646 |
|
Other funds holding CME
Compagnie Lombard Odier SCmA's CME Position: Q2 2026 in Review
Compagnie Lombard Odier SCmA reduced its CME Group (CME) stake by 43% in Q2 2026, selling an estimated $18.8K and leaving 92 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #408.
Compagnie Lombard Odier SCmA first reported a position in CME in Q4 2013 and has held it in 33 quarters since. The position peaked at $313K in Q4 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Compagnie Lombard Odier SCmA held 92 shares of CME Group worth $20.3K as of Q2 2026.
- Compagnie Lombard Odier SCmA sold 68 CME Group shares in Q2 2026, an estimated $18.8K.
- CME Group made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #408 holding.
- Compagnie Lombard Odier SCmA first reported a position in CME Group in Q4 2013 and has held it in 33 quarters since.
- Compagnie Lombard Odier SCmA's CME Group position peaked at $313K in Q4 2025.
- 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.